Drug recall · May 20, 2015
Levalbuterol Inhalation Solution recall
Why: Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Levalbuterol Inhalation Solution, USP, 0.31 mg/ 3 mL, 3 mL Vials, Rx Only. Manufactured by: Cipla Ltd. Plot 9 & 10, Indure, SEZ, Pithampur, M.P.-454 775, INDIA, Manufactured for: Dr. Reddy's Laboratories, Inc., Princeton NJ 08640. NDC: 43598-412-25.
- Lots / codes
Lot #: FA4022; Expiry: December 2015.
- Quantity
- 140,625 Vials
- Company
- Cipla Limited, Pithampur, District Dhar, N/A
- Distribution
- U.S. Nationwide including Puerto Rico.
- Initiated
- April 24, 2015 · Voluntary: Firm initiated
- Classified
- May 14, 2015
- Reported
- May 20, 2015
- Ended
- February 14, 2017
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levalbuterol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.